ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery

Overview of attention for article published in Frontiers in immunology, April 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 44,728 followers.

RT @FrontImmunol: New Research: ARTEMIS: a novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery: Conve…

17 May 2021

Reply Repost Favourite

New Research: ARTEMIS: a novel mass-spec platform for HLA-restricted self and disease-associated peptide discovery: Conventional immunoprecipitation/mass spectroscopy identification of HLA-restricted peptides remains the purview of… https://t.co/QZbHhrrI0d

17 May 2021

Reply Repost Favourite

ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery | https://t.co/xMq4wmQWSm #proteomics https://t.co/iPfugKLKsW

15 May 2021

Reply Repost Favourite

ARTEMIS: A Novel Mass-Spec Platform for HLA-Restricted Self and Disease-Associated Peptide Discovery #FrontImmunol https://t.co/6r03m2uBLq

15 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.